21 CFR 211.80
Procedures To Be in Writing
- Inspections citing it: 658
- Of those classified, ended OAI: 25%
- Last cited: FY2026
Inspections Citing It by Fiscal Year
Sites in and outside the US, FY2017 to Oct 20, 2026.
Paragraphs Cited
As FDA posts them, all years.
- 211.80(a)
- 406 · Procedures To Be in Writing
- 211.80(b)
- 148 · Handling and Storage to Prevent Contamination
- 211.80(d)
- 95 · Status of Each Lot Identified
- 211.80(c)
- 9 · Storage off Floor, Spaced Suitably
Regulation Text
eCFR did not answer; open it on eCFRRecently Cited Sites
Newest inspections citing this section; each opens the site- Steril-Gene Life Sciences Private LtdIndia · Aug 12, 2026
- The Flower Remedy LLCUnited States · Jun 12, 2026
- Advagen Holdings, Inc.United States · May 13, 2026
- GVS TM, IncUnited States · May 1, 2026
- Cosmetic Lab, Inc.United States · Mar 10, 2026
- Delta Kozmetik Sanayi Ve Ticaret-Selim YesilTürkiye · Mar 5, 2026
- Nice-Pak Products, LLCUnited States · Feb 5, 2026
- MEGHMANI LLPIndia · Feb 3, 2026
- Nelson Laboratories, LLCUnited States · Jul 30, 2025
- Atlantis Laboratories, Inc.United States · Jun 26, 2025
- World Perfumes Inc.United States · May 9, 2025
- United Therapeutic CorporationUnited States · Feb 11, 2025
Counts are inspections with posted citations that cite any paragraph of the section, once per inspection, from FDA's Data Dashboard. OAI share is over inspections FDA finally classified. Text from eCFR, the official online CFR. FDA Data Dashboard and eCFR